cas 2088458-39-1|| where to buy tert-butyl 5-oxo-1H-pyrazole-2-carboxylate

Produktname:tert-butyl 5-oxo-1H-pyrazole-2-carboxylate

IUPAC Name:tert-butyl 3-oxo-2,3-dihydro-1H-pyrazole-1-carboxylate

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM330037-250mg	in stock	Ÿœ
CM330037-1g	in stock	şǆƚ
CM330037-5g	in stock	ǆȤƴ
CM330037-10g	in stock	ƴœȤ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2088458-39-1 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:2088458-39-1; Molekulare Formel:C8H12N2O3; Schmelzpunkt:-; SMILES-Code:O=C(N(C=C1)NC1=O)OC(C)(C)C; Dichte:

: Katalognummer:CM330037; Molekulargewicht:184.19; Siedepunkt:; Mdl-Nr.:MFCD31742743; Lagerung:

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Vanzacaftor; Vertex Pharmaceuticals announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combination therapy for people living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vanzacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor is also undergoing regulatory review in multiple other jurisdictions, including by the Food and Drug Administration (FDA) in the U.S. and by the European Medicines Agency (EMA) in the E.U.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.